String-Attached stent may ease bile duct cancer surgery prep
NCT ID NCT05874934
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a plastic stent with a retrieval string to drain bile in 40 people with resectable bile duct cancer. The goal was to see if the stent could safely reduce bile buildup before surgery. Researchers measured serious complications and how well the stent worked.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- plastic biliary stent with retrieval string
- What this could lead to
- If successful, this stent could provide a safer, simpler way to drain bile before surgery, potentially reducing complications.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to everyone. The stent could still cause infections or other complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years or older. * Capable of providing written and oral informed consent. * Presumed perihilar cholangiocarcinoma. * Biliary obstruction in the future liver remnant. * Drainage naïve patients: total bilirubin \>50 umol/L * Patients with previous endobiliary drainage procedures: persistently rising total bilirubin \>50 umol/L (i.e. no stent placed or insufficient draining stent) or persistent biliary dilatation in the future liver remnant on imaging (i.e. previous stent placed in contralateral side of the liver). Exclusion Criteria: * Incompletely recovered from any side effects of previous biliary drainage procedures. Patients are required to be off antibiotic treatment for at least 5 days. * Any contra-indication for major liver surgery (e.g. ECOG/WHO score ≥3). * Technical contra-indications for endobiliary drainage (e.g. previous gastrojejunostomy). * Distance between stricture and sphincter less than 2 cm. * Refusal to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Perihilar cholangiocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC
Amsterdam, 1081HV, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Re-Assessing bile duct cancer treatment open the door to surgery?
- Burning away bile duct blockages: a new weapon against cholangiocarcinoma?
- Can a Pre-Surgery drug combo boost bile duct cancer survival?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- Can a One-Two punch of heat and drainage tame inoperable bile duct cancer?
- Heat therapy before stenting may extend bile duct patency in cancer patients